NuVasive Inc. Fourth Quarter Earnings Sneak Peek
NuVasive, Inc. (NASDAQ:NUVA) will unveil its latest earnings on Wednesday, February 22, 2012. NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders.
NuVasive, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for net income of 11 cents per share, a decline of 64.5% from the company’s actual earnings for the year-ago quarter. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. Analysts are projecting profit to rise by 39.1% versus last year to 56 cents.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by one cent, reporting profit of 14 cents per share against a mean estimate of net income of 13 cents per share.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a rise of 14.8% in revenue from the year-earlier quarter to $148.4 million.
Analyst Ratings: Analysts are bullish on NuVasive, as 10 analysts rate it as a buy, none rate it as a sell and 10 rate it as a hold.
A Look Back: In the third quarter, the company swung to a loss of $67.6 million ($1.69 a share) from a profit of $8.5 million (21 cents) a year earlier, but beat analyst expectations. Revenue rose 10.5% to $132.9 million from $120.3 million.
The company has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. Over that span, the company has averaged growth of 14.2%, with the biggest boost coming in the fourth quarter of the last fiscal year when revenue rose 20.9% from the year earlier quarter.
NuVasive’s loss in the latest quarter followed profits in the previous three quarters. The company reported a profit of $5.4 million in the second quarter, a profit of $2.4 million in the first and a profit of $61.9 million in the fourth quarter of the last fiscal year.
Stock Price Performance: Between December 19, 2011 and February 16, 2012, the stock price had risen $5.43 (49.1%), from $11.07 to $16.50. The stock price saw one of its best stretches over the last year between April 8, 2011 and April 18, 2011, when shares rose for seven straight days, increasing 7.3% (+$1.87) over that span. It saw one of its worst periods between November 11, 2011 and November 25, 2011 when shares fell for 10 straight days, dropping 19.7% (-$3.01) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories:
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com